Page last updated: 2024-08-24

3-iodobenzylguanidine and Huntington Disease

3-iodobenzylguanidine has been researched along with Huntington Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Assante, R; Cuocolo, A; De Michele, G; De Rosa, A; De Simini, G; Di Maio, L; Ferrara, IP; Nappi, C; Palmieri, GR; Pappatà, S; Peluso, S; Roca, A; Salvatore, E1
Bax, JJ; Delgado, V; Ng, ACT1

Other Studies

2 other study(ies) available for 3-iodobenzylguanidine and Huntington Disease

ArticleYear
Autonomic disorders and myocardial 123I-metaiodobenzylguanidine scintigraphy in Huntington's disease.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:2

    Topics: 3-Iodobenzylguanidine; Autonomic Nervous System Diseases; Heart; Humans; Huntington Disease; Iodine Radioisotopes; Myocardial Perfusion Imaging; Radiopharmaceuticals

2022
Autonomic dysfunction in Huntington's disease: A
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:2

    Topics: 3-Iodobenzylguanidine; Autonomic Nervous System Diseases; Humans; Huntington Disease; Iodine Radioisotopes

2022